The total return over the past 12 months is +61.56% vs. +16.94% for the S&P 500. So far it's up +42.49% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +61.56% | +11.12% | (4.06%) | +13.44% | +11.86% | +10.69% |
| Total Return CAGR | +61.56% | +11.12% | (4.06%) | +13.44% | +11.86% | +10.69% |
| Revenue CAGR | +13.94% | +15.92% | +18.57% | +14.83% | +15.78% | +15.13% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | +519.26% | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +78.25% | N/A | N/A | N/A | +29.48% | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
AtriCure, Inc. (ATRC)
| Year | Start price | End price | ATRC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $39.56 | $56.37 | +42.49% | +14.51% | +27.98% |
| 2025 | $30.56 | $39.56 | +29.45% | +17.72% | +11.73% |
| 2024 | $35.69 | $30.56 | (14.37%) | +24.89% | (39.26%) |
| 2023 | $44.38 | $35.69 | (19.58%) | +26.19% | (45.77%) |
| 2022 | $69.53 | $44.38 | (36.17%) | (18.17%) | (18.00%) |
| 2021 | $55.67 | $69.53 | +24.90% | +28.74% | (3.84%) |
| 2020 | $32.51 | $55.67 | +71.24% | +18.37% | +52.87% |
| 2019 | $30.60 | $32.51 | +6.24% | +31.22% | (24.98%) |
| 2018 | $18.24 | $30.60 | +67.76% | (4.56%) | +72.32% |
| 2017 | $19.57 | $18.24 | (6.80%) | +21.70% | (28.50%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
